As shown in Fig. 2A, knocking down p52-ZER6 clearly suppressed the expression of G6PD in breast cancer and hepatocellular cancer cells, while its overexpression had the opposite effect (Fig. 2B and Fig. S3A), suggesting that such regulatory action was common to various cancer types. This evidence concerns the gene G6PD and cancer.